3 research outputs found

    Assessment of phenotypes, physiological and behavioural responses associated with heat tolerance among Galla goats in North Eastern Kenya.

    Get PDF
    Galla goats have great adaptation vigor to different environments. However, the outcomes of the ongoing climate change have subjected livestock including the Galla goats to harsh environmental conditions like high ambient temperatures. In this study, Galla goats were characterized in the selected areas based on phenotypic, physiological, and behavioural responses to high environmental temperature. One hundred and forty-nine Galla goats selected from Isiolo, Garissa and Tana River were scored for various features such as coat colour, horn colour, skin colour, horn shape, horn length, ear orientation, ear length, wattles and horn circumference. Data collected were entered in an excel spread sheet then analyzed in R statistical software version 4.0.4. White was found to be the dominant coat colour with a percentage frequency greater than 60.0% in the studied counties. The study revealed that both male and female Galla goats possess horns with more than 88.9% of goats being horned across the three counties. There was a strong relationship between horn presence and the environmental temperature with p=0.05. A positive correlation was also observed between environmental temperature and rectal temperature, horn length, ear length and horn circumference. The findings show the presence of an important gene pool from which guidelines on conservation of heat stress phenotypes as a result of the ongoing climate change can be put in place

    Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya

    Get PDF
    Background: Pre-treatment HIV-drug-resistance (PDR) to WHO-recommended 1st-line non-nucleoside reverse transcriptase inhibitors (NNRTI)-based antiretroviral treatment (ART) is increasing in low-resource communities. We evaluated the risk of PDR on treatment failure if detected at single or multiple codons, at minority (2–9%) or higher (≥10%) frequencies during efavirenz- vs. nevirapine-ART. Methods: We conducted a pooled analysis across three cohorts of Kenyans initiating 1st-line NNRTI-ART between 2006 and 2014. Mutations K103N, Y181C, G190A, M184V and K65R were detected by an oligonucleotide ligation assay (OLA) and confirmed by Sanger and next-generation sequencing (NGS). PDR was defined as detection of any mutation by OLA when confirmed by NGS. Treatment failure, defined as plasma HIV RNA ≥400 copies/mL at month-12 of ART, was compared by PDR genotypes. Findings: PDR was detected in 59/1231 (4·8%) participants. Compared to wild-type genotypes, PDR in participants prescribed nevirapine-ART was associated with increased treatment failure [PDR 69·2% (27/39) vs. wild-type 10·4% (70/674); p = 0·0001], whether detected as minority [66·7% (4/6)] or higher [69·7% (23/33)] frequencies in an individual\u27s HIV quasispecies (p = 0·002 and p \u3c 0·0001, respectively), or mutations at single [50·0% (12/24)] or multiple [100·0% (15/15)] codons (p \u3c 0·0001). During efavirenz-ART, PDR was also associated with increased virologic failure [PDR 25·0% (5/20) vs. wild-type 5·0% (25/498); p = 0·005], but only if detected at multiple drug-resistant codons [50·0% (3/6); p = 0·003] or high frequencies PDR [33·3% (5/15); p = 0·001]. Interpretation: The risk that PDR confers for treatment failure varies by number of mutant codons and their frequency in the quasispecies, with a lower risk for efavirenz- compared to nevirapine-based regimens. PDR detection and management could extend the effective use of efavirenz-ART in low-resource settings. Funding: NIH, PEPFAR
    corecore